Loading insider details...
Beta
Latest Form 4 (Jun 17, 2026): Grant/Award of 7,000 KYNB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | KYNTRA BIO, INC. (KYNB) | Grant/Award | 7,000 | n/a |
| May 11, 2026 | Kezar Life Sciences, Inc. (KZR) | Tender of Shares | 6,369 | n/a |
| Jan 8, 2026 | Verastem, Inc. (VSTM) | Grant/Award | 200,000 | n/a |
| Nov 25, 2025 | Verastem, Inc. (VSTM) | Sale | 8,550 | $85.5K |
| Jun 23, 2025 | Kezar Life Sciences, Inc. (KZR) | Grant/Award | 5,000 | n/a |
| Jun 6, 2025 | FIBROGEN INC (FGEN) | Grant/Award | 70,000 | n/a |
| May 27, 2025 | Verastem, Inc. (VSTM) | Grant/Award | 8,333 | n/a |
| Aug 23, 2024 | Adicet Bio, Inc. (ACET) | Disposition to Issuer | 37,000 | n/a |
| Jun 21, 2024 | Kezar Life Sciences, Inc. (KZR) | Grant/Award | 50,000 | n/a |
| Jun 21, 2024 | Verastem, Inc. (VSTM) | Grant/Award | 8,333 | n/a |